Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline
11:07am, Tuesday, 28'th Oct 2025
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
12:39am, Friday, 24'th Oct 2025
Chicago Capital added 999,873 shares of Procept BioRobotics with an estimated purchase value of $45.65 million based on the average price for the quarter. The transaction represents a trade size equal
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
04:03pm, Wednesday, 15'th Oct 2025
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tr
Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader
12:30pm, Monday, 06'th Oct 2025
PROCEPT BioRobotics stands out in BPH therapy with its unique Aquablation technology and razor-and-blade business model, driving strong, recurring growth. PRCT's robust R&D investment, expanding indic
3 AI Growth Stocks to Turn $10K Into $50K in Short Order
02:00pm, Wednesday, 03'rd Sep 2025
It is tempting to believe the next Nvidia (NASDAQ:NVDA ) or Palantir (NASDAQ:PLTR ) is hiding in plain sight and will quickly give you multibagger returns.
Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy
05:24pm, Thursday, 14'th Aug 2025
Procept BioRobotics Corporation is in the early stages of penetrating a massive $20B BPH surgery market with its innovative, recurring-revenue robotic systems. The company's strong revenue and install
PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript
02:17am, Thursday, 07'th Aug 2025
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Kevin Waters - Executive VP & CFO Larry L. Wood - Independent Director Ma
Procept (PRCT) Q2 Revenue Jumps 48%
08:32pm, Wednesday, 06'th Aug 2025
Procept BioRobotics (PRCT -5.28%), a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia (BPH) treatment, posted second-quarter 2025 results on August
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
06:45pm, Wednesday, 06'th Aug 2025
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.5 per share a year ago.
PROCEPT BioRobotics (PRCT) Earnings Transcript
05:35pm, Wednesday, 06'th Aug 2025
Image source: The Motley Fool.
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
04:03pm, Wednesday, 06'th Aug 2025
SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
11:06am, Wednesday, 30'th Jul 2025
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
06:00pm, Thursday, 24'th Jul 2025
SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative s
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
08:00am, Wednesday, 23'rd Jul 2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transf
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
04:03pm, Monday, 21'st Jul 2025
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tr
